Skip to content

The stories shaping the United States, Canada, and the world.

This story is from the CurrentWire archive. Coverage details reflect the last time it was updated.

BusinessUnited StatesPress release

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership Role

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Period”). CLICK […]

Financial Post

Published by CurrentWire · First coverage

Compiled by CurrentWire News Desk

Summary based on reporting from Financial Post.

Read the full report at Financial Post(opens in a new tab)

Automated coverage analysis

Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.

Source mix

1 independent editorial domain

What coverage breadth measures

How CurrentWire compiled this story

Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 5 minutes later, on .

Filed under Business · United States · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: New York (13), Fox Encourages Capricor Therapeutics (none), CAPR Investors (none), Leadership Role (2).

CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.